Pharmaceutical Field Sales Representative
Aucta Pharmaceuticals Inc.
Summary
The Specialty Account Manager will be an integral part of a sales team developing and managing an assigned territory. The primary responsibility of the Sales Representative will be to develop and manage a designated regional territory with the goal of maximizing and reaching sales forecasts. Expectations for the Sales Representative include being a self-starter, a team player, and responsible for identifying, ranking, prospecting, and developing key neurology practices. This also includes hospital-based business relationships within the targeted regional territory. You will be overseeing and leading the identification of business opportunities, building and fostering customer relationships, and ensuring the effective presentation of Motpoly XR to meet/exceed sales forecasts and goals.
Job description
Key Responsibilities
- Effectively communicate appropriate, therapeutic, disease state, and product information to customers to successfully promote the use of Motpoly XR within the territory
- Utilize effective selling techniques and marketing strategies to create and expand Motpoly XR’s demand.
- Develop a business plan for the assigned territory that is consistent with Aucta’s sales plans, strategies, and objectives.
- Conducts quality sales conversations with all targeted customers.
- Achieve quarterly sales goals within the territory while adhering to all ethical sales practices and required regulations.
- Understands and demonstrates targeting principles.
- Develop pre-call planning strategy for key targets.
- Develop positive and interactive relationships with peers, customers, and Company support team members.
- Responsible for ensuring high levels of call and field productivity.
- Gathers and utilizes information from offices, pharmacists, and others to develop and implement specific strategies for territory prescribers.
- Leverages sample program, literature, and other items to ensure physician awareness of Aucta Products.
- Differentiates products from all competitors and responds to customer issues confidentially and appropriately.
- Actively pursue continuous learning and professional development on efficient sales, communication & product knowledge training.
Requirements
- Bachelor’s degree required.
- A minimum of 1-3 years of biotech/pharma sales and product promotion is required preferably in the CNS therapeutic area.
- Proven track record of consistent sales success and experience developing, implementing, executing, and monitoring success within each account.
- Successful launch experience preferred, preferably in the CNS therapeutic area.
- Proven business acumen with a strong track record of consistently exceeding territory performance goals.
- Demonstrated success in influence and negotiation skills.
- Excellent oral, written, interpersonal, and listening skills.
- Demonstrated leadership skills, including the ability to take initiative and drive results independently.
- Demonstrated ability to work independently and as a highly motivated self-starter within a team environment to deliver results.
- Ability to learn, apply, and effectively communicate products and disease states.
- Proficiency in Excel, Word, MS Teams, and Outlook.
- Flexibility to travel up to 30 percent, with potential variation based on territory size. Overnight stays may be required.
- Must live within the territory/geography of responsibility
- Possession of a valid Driver’s License with a clean driving record.
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401k
- Life Insurance
- Disability Insurance
- Paid Time Off
Company overview
Aucta Pharmaceuticals Inc. is a research-driven specialty pharmaceutical company founded in 2012 that focuses on developing and commercializing innovative medicines through the 505(b)(2) regulatory pathway. The company specializes in creating enhanced formulations of proven molecules to address high unmet clinical needs in therapeutic areas including central nervous system (CNS) disorders, ophthalmic conditions, inhalation therapy, and rare diseases. With operations in both New Jersey, USA and Shanghai, China, Aucta leverages established molecules with proven safety profiles to accelerate innovation and improve patient outcomes. The company's product portfolio includes branded specialty products and technology platform-based niche generics, with recent launches including PYQUVI oral suspension for Duchenne muscular dystrophy and MOTPOLY XR extended-release capsules for epilepsy. Aucta employs approximately 51-200 people and has raised $16 million in funding, with estimated annual revenues between $25-50 million. The company's strategic approach focuses on lower scientific risk development while fulfilling unmet medical needs through innovative dosage forms, dosing regimens, and new indications for existing therapeutic molecules.